LYELL LYFE MANUFACTURING CENTER

What this means for you

This application is over — abandoned 18 Dec 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number

90580477

Mark type

Stylized text

Filed

15 Mar 2021

Published for opposition

22 Mar 2022

Abandoned

18 Dec 2023

Attorney of record

Christina L. Martini

Goods and services

• Class 040 — Treatment of materials: Custom manufacture of pharmaceuticals
• Class 042 — Scientific and technological services: Pharmaceutical research and development; development of pharmaceutical preparations and drugs; development of pharmaceutical preparations and drugs for the treatment of cancer, auto-immune diseases, and infectious diseases; development of pharmaceutical preparations and drugs in the field of immunotherapy; development of pharmaceutical preparations and drugs in the field of cell therapy; scientific research and development; scientific laboratory services; medical and scientific research

Owner

• Lyell Immunopharma, Inc., South San Francisco, CA, US
• Lyell Immunopharma, Inc., South San Francisco, CA, US

Prosecution history

• 18 Dec 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
• 18 Dec 2023 — ABANDONMENT - NO USE STATEMENT FILED
• 16 May 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 12 May 2023 — SOU EXTENSION 2 GRANTED
• 12 May 2023 — SOU EXTENSION 2 FILED
• 12 May 2023 — SOU TEAS EXTENSION RECEIVED
• 01 Oct 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 29 Sept 2022 — SOU EXTENSION 1 GRANTED
• 29 Sept 2022 — SOU EXTENSION 1 FILED
• 29 Sept 2022 — SOU TEAS EXTENSION RECEIVED
• 17 May 2022 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
• 22 Mar 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 22 Mar 2022 — PUBLISHED FOR OPPOSITION
• 02 Mar 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 15 Feb 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER